Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma
Clinical trial NCT02598570 · COMPLETED
Trial details
- NCT number
- NCT02598570
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-12-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.